213 related articles for article (PubMed ID: 10631656)
1. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.
Jenkinson C; Fitzpatrick R; Brennan C; Bromberg M; Swash M
J Neurol; 1999 Nov; 246 Suppl 3():III16-21. PubMed ID: 10631656
[TBL] [Abstract][Full Text] [Related]
2. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.
Jenkinson C; Fitzpatrick R; Swash M; Jones G
Clin Rehabil; 2007 Mar; 21(3):266-72. PubMed ID: 17329284
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a short measure of health status for individuals with acute myocardial infarction: the myocardial infarction dimensional assessment scale (MIDAS).
Thompson DR; Jenkinson C; Roebuck A; Lewin RJ; Boyle RM; Chandola T
Qual Life Res; 2002 Sep; 11(6):535-43. PubMed ID: 12206574
[TBL] [Abstract][Full Text] [Related]
5. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
6. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).
Jenkinson C; Norquist JM; Fitzpatrick R
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):242-5. PubMed ID: 12531959
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis.
Gołąb-Janowska M; Honczarenko K; Stankiewicz J
Neurol Neurochir Pol; 2010; 44(6):560-6. PubMed ID: 21225518
[TBL] [Abstract][Full Text] [Related]
8. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.
Jenkinson C; Fitzpatrick R
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):70-3. PubMed ID: 11118250
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.
Jenkinson C; Fitzpatrick R; Brennan C; Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):33-40. PubMed ID: 12365067
[TBL] [Abstract][Full Text] [Related]
10. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.
Prell T; Gaur N; Stubendorff B; Rödiger A; Witte OW; Grosskreutz J
J Neurol Sci; 2019 Feb; 397():92-95. PubMed ID: 30597420
[TBL] [Abstract][Full Text] [Related]
11. Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire.
Alankaya N; Tülek Z; Özakgül A; Kaya A; Dik A
J Neurosci Nurs; 2019 Oct; 51(5):253-258. PubMed ID: 31469706
[TBL] [Abstract][Full Text] [Related]
12. The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients.
Jenkinson C; Levvy G; Fitzpatrick R; Garratt A
J Neurol Sci; 2000 Nov; 180(1-2):94-100. PubMed ID: 11090872
[TBL] [Abstract][Full Text] [Related]
13. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.
Norquist JM; Fitzpatrick R; Jenkinson C
Qual Life Res; 2004 Oct; 13(8):1409-14. PubMed ID: 15503836
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review.
Epton J; Harris R; Jenkinson C
Amyotroph Lateral Scler; 2009 Feb; 10(1):15-26. PubMed ID: 18752087
[TBL] [Abstract][Full Text] [Related]
16. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data.
Jenkinson C; Harris R; Fitzpatrick R
Amyotroph Lateral Scler; 2007 Apr; 8(2):90-5. PubMed ID: 17453636
[TBL] [Abstract][Full Text] [Related]
17. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40).
Jenkinson C; Peto V; Jones G; Fitzpatrick R
Clin Rehabil; 2003 Jul; 17(4):380-5. PubMed ID: 12785246
[TBL] [Abstract][Full Text] [Related]
18. The impact of physical impairment on emotional well-being in ALS.
Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.
Shamshiri H; Eshraghian MR; Ameli N; Nafissi S
Iran J Neurol; 2013; 12(3):102-5. PubMed ID: 24250914
[TBL] [Abstract][Full Text] [Related]
20. Rasch measurement in the assessment of amytrophic lateral sclerosis patients.
Norquist JM; Fitzpatrick R; Jenkinson C
J Appl Meas; 2003; 4(3):249-57. PubMed ID: 12904675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
